刘敏,刘春亮,梁国强,姚霏,张晓迪,陈婷,袁雅琴,吴士良.追毒方逆转三阴性乳腺癌MDA-MB-231细胞耐药的作用机制[J].南京中医药大学学报(社会科学版),2019,35(1):63-67. |
追毒方逆转三阴性乳腺癌MDA-MB-231细胞耐药的作用机制 |
Reverse Effect and Mechanism of Effective Components of Zhuidu Fang on Triple Negative Breast Cancer MDA-MB-231 Drug-Resistant Cells |
|
DOI: |
中文关键词: 关键词:追毒方 三阴性乳腺癌MDA-MB-231耐药细胞 β3GnT8 逆转耐药 |
英文关键词: Zhuidu Fang triple negative breast cancer MDA-MB-231 drug-resistance cells β3GnT8 reverse the drug-resistance |
基金项目: |
|
摘要点击次数: 870 |
全文下载次数: 737 |
中文摘要: |
目的 基于糖基转移酶β3GnT8探讨追毒方逆转三阴性乳腺癌MDA-MB-231细胞耐药的作用机制。方法 通过MTT法观察追毒方对MDA-MB-231耐药细胞增殖的抑制作用,通过转染β3GnT8得到高表达β3GnT8的MDA-MB-231/TAX细胞株,采用Western blot观察糖基转移酶β3GnT8和耐药蛋白BCRP、P-gp的表达,通过凝集素流式细胞术观察转染β3GnT8 MDA-MB-231/TAX细胞膜表面β3GnT8的荧光强度。结果 追毒方有效成分能明显抑制三阴性乳腺癌MDA-MB-231耐药细胞的增殖,作用72 h抑制率达到50.16%,能有效下调β3GnT8和耐药蛋白BCRP、P-gp的表达,并且β3GnT8的表达与BCRP、P-gp呈正相关。结论 追毒方可通过下调糖基转移酶β3GnT8,从而降低耐药蛋白BCRP、P-gp的表达,逆转三阴性乳腺癌MDA-MB-231细胞耐药性。 |
英文摘要: |
OBJECTIVE Based on glycosyltransferase β3GnT8, to investigate the mechanism of reverse effect on triple negative breast cancer MDA-MB-231 drug-resistance cells by Zhuidu Fang. METHODS The inhibition of MDA-MB-31 drug-resistance cells proliferation by Zhuidu Fang was detected by MTT assay. By interference and transfection of β3GnT8, high and low expressed β3GnT8 MDA-MB-231/TAX cell lines were obtained. Western blot was used to detect the protein expression of β3GnT8, and drug resistance protein BCRP and P-gp. Lectin flow cytometry was used to detect β3GnT8 fluorescence intensity on β3GnT8 transfected MDA-MB-231/TAX cells. RESULTS Zhuidu Fang effectively inhibited the proliferation of MDA-MB-231/TAX cells, and the inhibitory rate was 50.16% after 72 h. Zhuidu Fang significantly downregulated the protein expression of β3GnT8, BCRP and P-gp. The protein expression of β3GnT8 showed a positive correlation with BCRP and P-gp. CONCLUSION Zhuidu Fang can reverse the drug-resistance of MDA-MB-231 cell lines, which is associated with the downregulation of the expression of β3GnT8, BCRP and P-gp. |
查看全文
查看/发表评论 下载PDF阅读器 |
关闭 |